

Health Care: Drugs
AVANIR Pharmaceuticals (AVNR: NASDAQ)
$3.40 0.15 | 4.62%
05/23/13 - 04:00 PM ET
Insider Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Net Insider Transaction |
58,350 |
58,350 |
0 |
0 |
0 |
0 |
-190,125 |
| Shares Bought |
58,350 |
58,350 |
0 |
65,000 |
65,000 |
65,000 |
0 |
| Shares Sold |
0 |
0 |
0 |
65,000 |
65,000 |
65,000 |
190,125 |
Institutional Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Total Shares Held |
87.22M |
87.87M |
89.81M |
91.31M |
92.24M |
92.52M |
91.21M |
| Shares Bought |
3.47M |
3.33M |
4.02M |
3.81M |
6.42M |
6.81M |
6.65M |
| Shares Sold |
6.05M |
4.27M |
4.09M |
4.12M |
2.92M |
2.97M |
3.03M |
Partner Headlines for AVNR
- Avanir Pharmaceuticals Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 05.08.13 | 07:05 am
- Pre-Market Most Active for Apr 26, 2013 : NOK, QQQ, ASML, BAC, MTU, RESI, JCP, BCS, FB, AVNR, ZNGA, SPNC - NASDAQ 04.26.13 | 12:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- After-Hours Earnings Report for December 12, 2012 : AVNR, INTL - NASDAQ 12.12.12 | 07:12 pm
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel ... - GuruFocus 06.30.12 | 11:06 am
- Ultimate Stock Watch List for The Supreme Court's Health Care Ruling - Benzinga 06.28.12 | 09:06 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- Avanir Pharmaceuticals: Limelight On The Horizon - Seeking Alpha 02.17.12 | 06:02 am
- Canaccord Reiterates Buy, $6 PT on Avanir Pharmaceuticals - Benzinga 11.30.11 | 09:11 am